Stephen Marshall, MD
Urology · Laconia, NHNPI 1427285493
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $338 of the $515 with a category attached, or 65.6%. 9 manufacturers reported payments, led by Boston Scientific at 24.4% of the total. Reporting peaked in 2019 at $221 and has fallen 76.8% since, to $51 in 2024. That places this record below the midpoint for urology clinicians in NH, where the typical reported total is $863.
Across 21 payments — averaging $24.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$126
- Pfizer$92
- Astellas Pharma US Inc$85
- AbbVie$75
- Coloplast$72
- Tolmar Pharmaceuticals, Inc.$20
- plus $44 from 3 others
What the payments were for
- Food & beverage$33866%
- Education$17734%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 4 | $126 |
| Pfizer | 5 | $92 |
| Astellas Pharma US Inc | 1 | $85 |
| AbbVie(2 entities) | 5 | $75 |
| Coloplast | 2 | $72 |
| Tolmar Pharmaceuticals, Inc. | 1 | $20 |
| Progenics Pharmaceuticals, Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $13 |
| Blue Earth Diagnostics | 1 | $12 |
How this compares
$515 in reported general payments places this provider in the 35th percentile of 61 urology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 21 | $15,071 |
| Tamsulosin Hcl | 437 | $6,202 |
| Mirabegron ErMirabegron | 11 | $2,894 |
| Finasteride | 165 | $2,300 |
| Potassium Citrate ErPotassium Citrate | 24 | $2,057 |
| Methenamine Hippurate | 18 | $1,555 |
| Solifenacin Succinate | 11 | $1,398 |
| Testosterone Cypionate | 20 | $760 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 19 | $464 |
| Oxybutynin Chloride ErOxybutynin Chloride | 23 | $419 |
| Doxazosin Mesylate | 26 | $403 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 16 | $256 |
| Bicalutamide | 12 | $188 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 15 | $170 |
| Nystatin | 16 | $168 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $85 | $15,07121 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 61 urology providers in New Hampshire.
Other urology in Laconia
- Frederic FernholzLaconia$436
- Martin GrossKeene$172K
- Ramiro Madden-FuentesConcord$82K
- Jason AkermanManchester$53K
- Lori LernerLebanon$49K
- E William JohnsonExeter$27K
- John MunozManchester$15K
- Arnold WillisKeene$15K
- Samuel SnipesManchester$6K
- Matthew JohnsonNashua$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.